Hints and tips:
...It is also suing Cognizant Technology Solutions and is co-lead plaintiff in a case against Allergan over an alleged generic drug price-fixing scheme....
...All of this was bad news for US-listed — but Irish-incorporated — pharmaceutical company Allergan, which announced in November that it had accepted a $160bn bid from Pfizer....
...The sale has ended an acrimonious and complex three-way battle: Teva had been in the throes of a hostile $40.1bn bid for rival Dutch incorporated generics company Mylan, which in turn is seeking a hostile...
...It comes after Netherlands-incorporated Mylan, one of the world’s biggest makers of generic medicines, waged an aggressive defence including a complex “poison pill” arrangement and frequent mudslinging....
...Buried in page 27 of Valeant’s recent quarterly regulatory filing was some potentially significant news: the pharmaceutical company, currently pursuing a $53bn hostile takeover of Allergan, is under investigation...
...Assets sit at a record $74.2bn, according to eVestment – and with Bill Ackman’s Pershing Square teaming up with a hostile bidder for Botox maker Allergan this week, the activists’ ambitions are growing....
...They include the record-breaking $2.3bn fine imposed on Pfizer last year for aggressive marketing practices, as well as actions against AstraZeneca, Elan, Novartis, Allergan, Forest, Teva, Mylan and Eli...
International Edition